Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 13/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.38 |
| ▸ | TACR3 | P29371 | 2/20 | 0.36 |
| ▸ | CETP | P11597 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | ENO1 | P06733 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28793950 | 0.96 | TACR1 (0.41) | TACR1DPP8DPP9DPP7GRIN2B | |
| SCHEMBL27746410 | 0.84 | TACR1 (0.40) | TACR1CETP | |
| SCHEMBL27767315 | 0.80 | TACR1 (0.48) | TACR1DPP8DPP9DPP7TACR3 | |
| SCHEMBL27746436 | 0.80 | CETP (0.43) | TACR1TACR3CETP | |
| SCHEMBL27767322 | 0.78 | ABCB1 (0.39) | CETPENO1 | |
| SCHEMBL3950021 | 0.78 | CETP (0.57) | TACR1CETP | |
| SCHEMBL27613052 | 0.75 | ACHE (0.54) | TACR1GRIN2B | |
| SCHEMBL757682 | 0.75 | CETP (0.51) | TACR1CETP | |
| SCHEMBL757683 | 0.75 | CETP (0.51) | TACR1CETP | |
| SCHEMBL9885647 | 0.75 | CETP (0.51) | TACR1CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101490035-B | Amino-piperidine derivatives as CETP inhibitors | NOVARTIS AG | 2013-02-13 | — | — | CN | disclosed |
| CN-101490035-A | Amino-piperidine derivatives as CETP inhibitors | NOVARTIS AG (CH) | 2009-07-22 | — | — | CN | disclosed |